We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Randox Laboratories

Provides global diagnostic solutions for hospital laboratories, forensic laboratories, research laboratories, pharmac... read more Featured Products: More products

Download Mobile App





Randox Presents Full Suite of Reagent, Analyzer, and Quality Control Innovations

By LabMedica International staff writers
Posted on 19 Nov 2025

Randox is emphasizing its global reach and multi-disciplinary diagnostic offering at MEDICA 2025. More...

Exhibiting in Hall 3, Stand A08, the company is presenting a broad, integrated portfolio of reagents, analyzers and quality-control solutions designed to support laboratories, hospitals and point-of-care testing networks.

New innovations being spotlighted include the RABTA (Random Access Biochip Technology Analyser), a high-throughput, random-access platform designed for uninterrupted workflows and increased productivity. The RABTA incorporates Biochip Array Technology to deliver up to 44 results from a single sample, provides the first result in just 36 minutes, and processes up to 60 samples per hour. With rapid random-access capabilities, the analyzer provides precise and reliable results across a wide range of assays.

Also on display is the Vivalytic platform, a fully automated, all-in-one molecular diagnostics system developed in partnership with Bosch. Vivalytic consolidates extraction, amplification, and detection into a compact benchtop instrument. The cartridge-based workflow supports both high-plex and low-plex testing, and Randox Multiplex Biochip Technology enables the generation of multiple results from a single patient sample.

The Acusera Smart Controls range is another highlight. These third-party quality-control materials load directly onto analyzers to streamline QC workflows, reduce operator error, and consolidate control materials across multiple analytes and platforms. The range includes controls for clinical chemistry, immunoassay, liquid cardiac markers, and PTH. By eliminating the need to locate product inserts, manually enter QC ranges, or pipette and aliquot materials, the Acusera Smart range can save laboratories up to 60 minutes of valuable time per control.

In addition to these featured systems, Randox offers an extensive portfolio of open-channel reagents for clinical chemistry and immunoassay testing, quality-assurance solutions, and multiparametric testing panels powered by its Biochip Array Technology. Visitors to the Randox booth can learn about the company's comprehensive product range, cost-effective solutions, innovative technologies, and global reach and support.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
All-in-One Molecular System
AIO M160
HPV Test
Allplex HPV28 Detection
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The researchers Manel Pérez Pons y Carlos Rodriguez Muñoz at the IRBLleida laboratory (Photo courtesy of IRBLleida)

New Blood RNA Markers Help Advance Precision Medicine for Respiratory Patients

Risk stratification in hospitalized respiratory disease, particularly among older adults with COVID-19, remains challenging despite rich clinical datasets. Blood-based non-coding RNA biomarkers are promising,... Read more

Microbiology

view channel
Image: The “broth” used to monitor red blood cell depletion in whole blood spiked with one colony-forming-unit of E. coli bacteria, each incubated at different orbital shaking speeds—left to right: 0 RPM, 65 RPM, 120 RPM and 200 RPM—after four hours of incubation. This culturing raises a bacteria-rich, plasma-like layer of bacteria to the top of the vials, while clusters of stuck blood cells known as a Rouleaux formation sink to the bottom. (Image Credit: Pak Kin Wong)

New Diagnostic Workflow Identifies Bloodstream Pathogens and Antibiotic Response in Hours

Sepsis is a life-threatening complication of infection that affects more than 1.5 million patients annually in the United States and contributes to roughly one in three in-hospital deaths.... Read more

Pathology

view channel
Image: Researchers evaluated AI models that quantify tumor-infiltrating lymphocytes (TIL) on routine breast tissue slides, where higher TIL levels reflect stronger antitumor response and improved breast cancer outcomes (Image Credit: Shutterstock)

AI Matches Pathologists in Predicting Breast Cancer Prognosis from Immune Cells

Breast cancer is the most common cancer in Australian women, with more than 20,000 cases each year. Prognosis can be informed by counting tumor-infiltrating lymphocytes (TILs) on routine pathology slides,... Read more

Industry

view channel
Image: RaDaR ST uses a tumor-informed approach that identifies up to 48 patient-specific variants through whole-exome sequencing and tracks those variants in plasma to detect circulating tumor DNA (ctDNA) at very low variant allele fractions (VAFs) (Photo courtesy of Neogenomics)

Tumor-Informed MRD Assay Gains Medicare Coverage for Immunotherapy Monitoring

NeoGenomics’ RaDaR ST molecular residual disease (MRD) assay has received expanded coverage from the Centers for Medicare & Medicaid Services’ Molecular Diagnostic Services Program (MolDX) for monitoring... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.